首页 > 最新文献

Anaesthesia最新文献

英文 中文
Rapid sequence induction with target-controlled infusions: a technical simulation study 靶控输注快速序列诱导:技术模拟研究
IF 6.9 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-14 DOI: 10.1111/anae.70078
Andrea Gentile, Michele Introna, Michel M. R. F. Struys, Johannes P. van den Berg
<p>Target-controlled infusions have been criticised as too slow for a rapid sequence induction (RSI), due primarily to the maximum infusion rate of commercially available pumps (approximately 1200 ml.h<sup>-1</sup>). Despite the widespread adoption of total intravenous anaesthesia, there is limited consensus on what truly defines a ‘rapid’ induction of general anaesthesia, and no standardised description of RSI components exists [<span>1</span>]. A new feature in commercial target-controlled infusion pumps enables administration of an additional manual bolus to accelerate induction of anaesthesia [<span>2</span>]. The rationale relies on comparing a 5 s manual bolus with a capped 1200 ml.h<sup>-1</sup> infusion rate, supported by proof-of-concept simulation in a single virtual subject. This study extends that concept by providing a simulation-based pharmacokinetic proof of feasibility for target-controlled infusions use in RSI.</p><p>Simulations were performed using the Python Anaesthesia Simulator [<span>3</span>], which incorporates the Eleveld population model for propofol. Virtual patients were defined as 35-year-old males, 175 cm in height, with bodyweights ranging from 40 kg to 160 kg and assuming concomitant opioid administration. To isolate the effect of bodyweight on model performance and infusion limitations, we kept age, sex, height and opioid co-administration fixed across simulations, varying weight only. This approach ensured that differences in onset dynamics were attributable to weight-dependent changes in pharmacokinetics and to the infusion-rate cap of the pump, rather than to covariate interactions. Using propofol 1%, three induction doses were evaluated (1.5, 2.0 and 2.5 mg.kg<sup>-1</sup>), administered by two modalities: target-controlled infusion at a high infusion rate of 1200 ml.h<sup>-1</sup>; and a manual bolus delivered at 3360 ml.h<sup>-1</sup>. Without standardised guidelines for propofol administration during RSI, a manual bolus of 2 mg.kg<sup>-1</sup> over 15 s in a 70 kg patient was assumed. Simulation infusions continued until the full dose was delivered.</p><p>Time to peak effect-site concentration was used as a marker of induction speed, while peak plasma concentration of propofol served as a surrogate for risk of overshoot and haemodynamic instability. Although these indices do not capture loss of consciousness directly or clinical responses, they provide mechanistically relevant markers of onset dynamics, including the trajectory of the effect-site of propofol and systemic exposure. Primary outputs included: plasma and effect-site propofol concentration trajectories; time to peak effect-site concentration; maximum plasma site concentration; duration of infusion; and area under the curve at time-to-peak effect-site concentration. Results were summarised as median (IQR [range]) across bodyweights, with relative differences in proportions reported for time to peak effect-site and plasma concentration.</p><p>Acro
靶标控制输注被批评为对于快速序列诱导(RSI)来说太慢,主要是由于市售泵的最大输注速率(约1200 ml.h-1)。尽管全静脉麻醉已被广泛采用,但对于“快速”诱导全身麻醉的真正定义仍存在有限的共识,并且没有对RSI成分的标准化描述[10]。在商业目标控制输注泵的新功能,使管理额外的手动丸加速诱导麻醉[2]。其原理是将5秒的手动注射剂量与上限1200ml .h-1的注射速率进行比较,并在单个虚拟受试者中进行概念验证模拟。本研究扩展了这一概念,提供了基于模拟的药代动力学证据,证明了靶控输液用于RSI的可行性。使用Python麻醉模拟器[3]进行模拟,其中包含异丙酚的Eleveld种群模型。虚拟患者定义为35岁男性,身高175厘米,体重40 - 160公斤,同时服用阿片类药物。为了分离体重对模型性能和输注限制的影响,我们在模拟过程中保持年龄、性别、身高和阿片类药物联合给药固定,仅改变体重。这种方法确保了发病动力学的差异可归因于药代动力学的体重依赖性变化和泵的输注速率上限,而不是协变量相互作用。使用1%异丙酚,评估三种诱导剂量(1.5、2.0和2.5 mg)。Kg-1),分两种给药方式:靶控输注,高输注速率1200 ml.h-1;手动注射速度为每小时3360毫升。在RSI期间没有标准化的异丙酚给药指南,手动剂量为2mg。假设70kg患者的kg-1大于15s。模拟输注一直持续到给药完毕。效应位点浓度达到峰值的时间作为诱导速度的标志,而异丙酚的血浆峰值浓度作为超调风险和血流动力学不稳定的替代指标。虽然这些指标不能直接捕捉意识丧失或临床反应,但它们提供了发病动力学的机械相关标记,包括异丙酚作用部位和全身暴露的轨迹。主要产出包括:血浆和效应场异丙酚浓度轨迹;效应场浓度达到峰值的时间;最大血浆部位浓度;输注时间;曲线下面积为峰值效应点浓度。结果总结为体重的中位数(IQR[范围]),报告的比例在达到峰值效应位点和血浆浓度的时间上存在相对差异。在所有体重范围内(40-160 kg),靶控输注和手动输注在作用时间至峰值时的效应部位浓度几乎相同,在所有剂量下相差1%(表1和图1a)。这表明,尽管输注方式不同,但靶控输注保持了与诱导相关的效应位点动力学。相比之下,靶控输注的峰值时间效应持续较长,显示出剂量依赖性延迟增加:1.5 mg.kg-1时增加8%;2.0 mg.kg-1 12%;在2.5毫克时占14%kg-1(图1b)。这些差异在权重上保持适度,仅反映了对效应场平衡时间的最小实际影响。血浆异丙酚浓度峰值表现出最明显的差异,在靶控输注时减弱。与手动注射相比,靶控输注在1.5、2.0和2.5 mg时可使最大血浆部位浓度分别降低约14%、19%和22%。分别为kg-1,在高剂量和低体重下观察到更大的相对减少(图1c)。表1。在考虑的体重范围内,模拟每个异丙酚剂量的药代动力学指标。取值为数字或中位数(IQR [range])。诱导剂量;mg.kg-1靶控输注;手动输注;% -峰时效应场浓度;μg.ml-11.53.43 -3.5(3.4[3.4—-3.5])3.40 -3.4(3.4[3.4—-3.5])0.9 -1.2(0.5[0.2—-1.5])2.04.55 -4.6(4.5[4.5—-4.6])4.53 -4.6(4.5[4.5—-4.6])0.4 -0.7(0.2[0.0—-1.0])2.55.72 -5.7(5.7[5.7—-5.8])5.69 -5.7(5.7[5.7—-5.8])0.5 -0.8(0.3[0.1—-1.1])Time-to-peak效果;s1.5195(190-201[185-210])181(176-187[172-194])8.1(5.4-11.8[3.5-13.0])2.0211(210-212[208-213])188(182-196[176-200])11.7(7.7-15.9[5.5-19.0])2.5229(226-232[222-238])200(194-205[190-212])14.1(9.6-19.6[8.0-22.0])峰值血药浓度;μg.ml-11.514.85 -15.6(13.9[13.4—-16.3])17.21 -19.2(15.8[15.2—-20.1])-13.8(-20.1 - -9.5[-25.0 - -6.0])2.020.05 -21.1(17.7[17.0—-22.5])24.67 -29.0(20.5[19.5—-30.5])-18.7(-27.3 - -13.4[-31.0 - -10.0])2.526.70 -30.2(23.1[22.0—-31.5])32.88(27.9 - -38.7(26.5 -40。 2])-22.2(-30.4至-16.1[-35.0至-12.0])图1打开图查看器powerpoint (a)手动(红色)和靶控(蓝色)效应位点(实线)和血浆(虚线)浓度在2.0 mg.kg-1时的时间过程。实线和虚线显示为体重范围40-160公斤的中位数(IQR[范围])(阴影带)。与时间轴相交的垂直虚线表示体重40-160 kg范围内IQR(阴影带)达到峰值效果的中位时间。(b)靶控剂量和手动剂量在40-160 kg体重范围内达到峰值时间效应的相对差异(剂量方案:1.5 mg)。Kg-1(橙色线);2毫克。Kg-1(绿线);2.5毫克。Kg-1(紫色线)。(c)每种剂量方案中靶控剂量和手动剂量在体重40-160 kg范围内最大血浆浓度的相对差异:1.5 mg。Kg-1(橙色线);2毫克。Kg-1(绿线);2.5毫克。Kg-1(紫色线)。由于缺乏更新的指南,靶控输注治疗RSI的使用最近获得了新的关注。我们的模拟表明,靶控输注,即使在最大泵速下,也能在很宽的体重范围内实现与RSI兼容的效应位点动力学。与手动给药相比,靶控输注在达到效应位点浓度峰值的时间上仅造成适度延迟(约10秒),同时持续降低峰值血浆水平,这表明在限制不良反应方面具有潜在优势。重要的是,效应位点动力学得到了保留,这表明药效学的开始在很大程度上得到了维持。效应场浓度达到峰值的时间反映了等离子体和效应场区室之间的平衡延迟,主要由效应场速率常数决定,而不是等离子体剖面;因此解释了观察到的输液方式之间的最小差异。虽然仅限于药代动力学替代物,但这些结果提供了技术上的概念证明。效区浓度和血药浓度峰前时间不能直接预测临床终点,因此临床验证至关重要。然而,催眠的开始是已知的取决于效应位点的平衡,而不是等离子体峰值[5]。在这种情况下,手动给药可能过于激进,特别是对于血流动力学不稳定或肥胖的患者,血浆超调会增加风险[6-8]。我们的模拟表明,靶控输注平滑了血浆动力学,保留了效应位点暴露,并在不延迟发病的情况下达到了RSI浓度。这些发现挑战了目标控制输注对RSI治疗太慢的普遍看法,相反,支持其不劣于手动给药,提供更可控和潜在更安全的药代动力学特征。
{"title":"Rapid sequence induction with target-controlled infusions: a technical simulation study","authors":"Andrea Gentile,&nbsp;Michele Introna,&nbsp;Michel M. R. F. Struys,&nbsp;Johannes P. van den Berg","doi":"10.1111/anae.70078","DOIUrl":"10.1111/anae.70078","url":null,"abstract":"&lt;p&gt;Target-controlled infusions have been criticised as too slow for a rapid sequence induction (RSI), due primarily to the maximum infusion rate of commercially available pumps (approximately 1200 ml.h&lt;sup&gt;-1&lt;/sup&gt;). Despite the widespread adoption of total intravenous anaesthesia, there is limited consensus on what truly defines a ‘rapid’ induction of general anaesthesia, and no standardised description of RSI components exists [&lt;span&gt;1&lt;/span&gt;]. A new feature in commercial target-controlled infusion pumps enables administration of an additional manual bolus to accelerate induction of anaesthesia [&lt;span&gt;2&lt;/span&gt;]. The rationale relies on comparing a 5 s manual bolus with a capped 1200 ml.h&lt;sup&gt;-1&lt;/sup&gt; infusion rate, supported by proof-of-concept simulation in a single virtual subject. This study extends that concept by providing a simulation-based pharmacokinetic proof of feasibility for target-controlled infusions use in RSI.&lt;/p&gt;&lt;p&gt;Simulations were performed using the Python Anaesthesia Simulator [&lt;span&gt;3&lt;/span&gt;], which incorporates the Eleveld population model for propofol. Virtual patients were defined as 35-year-old males, 175 cm in height, with bodyweights ranging from 40 kg to 160 kg and assuming concomitant opioid administration. To isolate the effect of bodyweight on model performance and infusion limitations, we kept age, sex, height and opioid co-administration fixed across simulations, varying weight only. This approach ensured that differences in onset dynamics were attributable to weight-dependent changes in pharmacokinetics and to the infusion-rate cap of the pump, rather than to covariate interactions. Using propofol 1%, three induction doses were evaluated (1.5, 2.0 and 2.5 mg.kg&lt;sup&gt;-1&lt;/sup&gt;), administered by two modalities: target-controlled infusion at a high infusion rate of 1200 ml.h&lt;sup&gt;-1&lt;/sup&gt;; and a manual bolus delivered at 3360 ml.h&lt;sup&gt;-1&lt;/sup&gt;. Without standardised guidelines for propofol administration during RSI, a manual bolus of 2 mg.kg&lt;sup&gt;-1&lt;/sup&gt; over 15 s in a 70 kg patient was assumed. Simulation infusions continued until the full dose was delivered.&lt;/p&gt;&lt;p&gt;Time to peak effect-site concentration was used as a marker of induction speed, while peak plasma concentration of propofol served as a surrogate for risk of overshoot and haemodynamic instability. Although these indices do not capture loss of consciousness directly or clinical responses, they provide mechanistically relevant markers of onset dynamics, including the trajectory of the effect-site of propofol and systemic exposure. Primary outputs included: plasma and effect-site propofol concentration trajectories; time to peak effect-site concentration; maximum plasma site concentration; duration of infusion; and area under the curve at time-to-peak effect-site concentration. Results were summarised as median (IQR [range]) across bodyweights, with relative differences in proportions reported for time to peak effect-site and plasma concentration.&lt;/p&gt;&lt;p&gt;Acro","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"81 3","pages":"430-433"},"PeriodicalIF":6.9,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/epdf/10.1111/anae.70078","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145516216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-year follow-up of survival and health-related quality of life in patients with medical conditions admitted acutely to hospital in Malawi and Tanzania 马拉维和坦桑尼亚急性住院患者的生存和健康相关生活质量的一年随访
IF 6.9 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-14 DOI: 10.1111/anae.70083
Nateiya M. Yongolo, Ibrahim G. Simiyu, Stephen A. Spencer, Eve Worrall, Ben Morton, the Multilink Consortium
<p>Multimorbidity, defined as the coexistence of two or more long-term conditions, is a major public health issue. In southern and eastern Africa, limited access to primary care frequently results in delayed diagnosis and chronic disease decompensation with the need for acute hospital admission [<span>1</span>]. This report details 1-year survival and health-related quality of life (HRQoL) data in patients admitted acutely to hospitals in Malawi and Tanzania and follows on from our study that detailed the high prevalence of hypertension (44%); HIV (31%); and diabetes mellitus (27%) in patients admitted to hospital [<span>2</span>].</p><p>We conducted this study in line with our published protocol [<span>3</span>] and with statistical methodology replicated from our multicentre cohort study [<span>2</span>]. Patients were categorised based on the number (none, one and two or more) of long-term conditions. The 1-year follow-up for all patients was completed in December 2024. We evaluated 1-year survival and HRQoL (where a score of 1 represents perfect health and a score of 0 represents death) in survivors using EQ5D-5l. We have provided an open access link to our database hosted at: https://publications.mlw.mw. The 1-year survival analysis for this study was performed in R (4.4.1; R Studio for Statistical Computing, Vienna, Austria) using the survival, survminer and ggplot2 packages and HRQoL analysis was conducted in Stata MP 18.0 (StataCorp, College Station, TX, USA).</p><p>A total of 1407 patients, 657 (47%) female, were recruited to the cohort study between September 2022 and July 2023. One-year outcomes were available for 1244 (88%) patients, with 551 (44%) deaths recorded. There were 161 (11%) patients lost to follow-up at 1 year, and two patients withdrew from the study. There were 416 (54%) deaths at 1 year among those with two or more long-term conditions (Table 1 and online Supporting Information Figure S1). After adjusting for age, sex, universal vital assessment (a context-sensitive early warning score [<span>4</span>]) and site, patients with two or more long-term conditions had a higher risk of mortality compared with those with one long-term condition (hazard ratio 1.89, 95%CI 1.32–2.70) (Fig. 1, online Supporting Information Tables S1 and S2).</p><p>In the unadjusted analysis, the adjusted median (IQR [range]) 1-year HRQoL was lower in patients with two or more long-term conditions compared with those with one long-term condition (0.783 (0.625–1.000 [-0.743–1.000]) vs. 1.000 (0.799–1.000 [-1.069–1.000]), p < 0.001). After adjustment, however, this difference was not statistically significant: coefficient -0.02, 95%CI -0.04 to -0.003, p < 0.095 (online Supporting Information Figure S2 and Table S3).</p><p>We found lower survival for patients with long-term conditions, most commonly HIV, hypertension and diabetes mellitus. This is important because complications from these primary chronic communicable and non-communicable diseas
多重发病是指两种或两种以上长期疾病并存,是一个重大的公共卫生问题。在南部和东部非洲,获得初级保健的机会有限,常常导致诊断延误和慢性疾病失代偿,需要紧急住院。该报告详细介绍了马拉维和坦桑尼亚医院急性住院患者的1年生存率和健康相关生活质量(HRQoL)数据,并遵循了我们的研究,详细介绍了高血压的高患病率(44%);艾滋病毒(31%);住院患者中有糖尿病(27%)。我们按照我们公布的方案[3]和从我们的多中心队列研究[2]复制的统计方法进行了这项研究。患者根据长期疾病的数量(无、一种、两种或更多)进行分类。所有患者的1年随访于2024年12月完成。我们使用EQ5D-5l评估幸存者的1年生存率和HRQoL(1分代表完全健康,0分代表死亡)。我们提供了一个到我们的数据库的开放访问链接:https://publications.mlw.mw。本研究的1年生存分析在R (4.4.1; R Studio for Statistical Computing, Vienna, Austria)中使用survival, survminer和ggplot2软件包进行,HRQoL分析在Stata MP 18.0 (StataCorp, College Station, TX, USA)中进行。在2022年9月至2023年7月期间,共有1407名患者被招募到队列研究中,其中657名(47%)为女性。1244例(88%)患者获得了一年的结果,其中551例(44%)死亡。有161例(11%)患者在1年后失去随访,2例患者退出研究。在患有两种或两种以上长期疾病的患者中,1年内有416例(54%)死亡(表1和在线支持信息图S1)。在调整了年龄、性别、通用生命评估(一个上下文敏感的早期预警评分[4])和地点后,有两种或两种以上长期疾病的患者比只有一种长期疾病的患者有更高的死亡风险(风险比1.89,95%CI 1.32-2.70)(图1,在线支持信息表S1和S2)。在未经调整的分析中,有两种或多种长期疾病的患者1年HRQoL的调整中位数(IQR[范围])低于有一种长期疾病的患者(0.783(0.625-1.000[-0.743-1.000])和1.000 (0.799-1.000 [-1.069-1.000]),p < 0.001)。但调整后,差异无统计学意义:系数-0.02,95%CI -0.04 ~ -0.003, p < 0.095(在线支持信息图S2和表S3)。我们发现长期患病的患者生存率较低,最常见的是艾滋病、高血压和糖尿病患者。这一点很重要,因为如果在继发性并发症发生之前加强卫生系统,这些原发性慢性传染性和非传染性疾病的并发症就有可能得到缓解。例如,我们发现心力衰竭的患病率很高(11%);脑血管意外(9%);慢性肾脏疾病(6%)在我们的队列研究bbb中。如何最好地支持卫生系统和卫生保健工作者提供这些干预措施(例如改进诊断、药物和以患者为中心的护理)是需要解决的一个关键问题。我们建议在已建立的艾滋病毒感染者垂直卫生系统的基础上,为这些环境中的住院患者制定综合护理规划。据我们所知,这是对非洲南部和东部多病住院患者长期预后的首次检查。我们的研究结果与高收入国家的数据形成对比,高收入国家报告的多病bbb患者的死亡率(6%对3%的住院死亡率)和再入院率(1年后39%对25%)更高。我们的HRQoL数据也与先前的研究一致,这些研究报告HRQoL随着入院后90天病情数量的增加而呈剂量依赖性降低[6,7],但在1年的幸存者中未观察到这种影响。在坦桑尼亚和马拉维等资源有限的卫生系统中,应对这一挑战需要双重重点,即为已受影响的人提供适当的护理,同时在初级卫生保健机构中优先考虑初级预防战略,以促进人口健康。在南部和东部非洲,多发病与住院患者预后不良有关,入院1年后死亡率持续上升。未来的研究应确定与当地相关的风险状况,并测试卫生系统层面的干预措施,以更好地控制慢性病,预防急性代偿失调,减轻多病的长期健康后果。
{"title":"One-year follow-up of survival and health-related quality of life in patients with medical conditions admitted acutely to hospital in Malawi and Tanzania","authors":"Nateiya M. Yongolo,&nbsp;Ibrahim G. Simiyu,&nbsp;Stephen A. Spencer,&nbsp;Eve Worrall,&nbsp;Ben Morton,&nbsp;the Multilink Consortium","doi":"10.1111/anae.70083","DOIUrl":"10.1111/anae.70083","url":null,"abstract":"&lt;p&gt;Multimorbidity, defined as the coexistence of two or more long-term conditions, is a major public health issue. In southern and eastern Africa, limited access to primary care frequently results in delayed diagnosis and chronic disease decompensation with the need for acute hospital admission [&lt;span&gt;1&lt;/span&gt;]. This report details 1-year survival and health-related quality of life (HRQoL) data in patients admitted acutely to hospitals in Malawi and Tanzania and follows on from our study that detailed the high prevalence of hypertension (44%); HIV (31%); and diabetes mellitus (27%) in patients admitted to hospital [&lt;span&gt;2&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;We conducted this study in line with our published protocol [&lt;span&gt;3&lt;/span&gt;] and with statistical methodology replicated from our multicentre cohort study [&lt;span&gt;2&lt;/span&gt;]. Patients were categorised based on the number (none, one and two or more) of long-term conditions. The 1-year follow-up for all patients was completed in December 2024. We evaluated 1-year survival and HRQoL (where a score of 1 represents perfect health and a score of 0 represents death) in survivors using EQ5D-5l. We have provided an open access link to our database hosted at: https://publications.mlw.mw. The 1-year survival analysis for this study was performed in R (4.4.1; R Studio for Statistical Computing, Vienna, Austria) using the survival, survminer and ggplot2 packages and HRQoL analysis was conducted in Stata MP 18.0 (StataCorp, College Station, TX, USA).&lt;/p&gt;&lt;p&gt;A total of 1407 patients, 657 (47%) female, were recruited to the cohort study between September 2022 and July 2023. One-year outcomes were available for 1244 (88%) patients, with 551 (44%) deaths recorded. There were 161 (11%) patients lost to follow-up at 1 year, and two patients withdrew from the study. There were 416 (54%) deaths at 1 year among those with two or more long-term conditions (Table 1 and online Supporting Information Figure S1). After adjusting for age, sex, universal vital assessment (a context-sensitive early warning score [&lt;span&gt;4&lt;/span&gt;]) and site, patients with two or more long-term conditions had a higher risk of mortality compared with those with one long-term condition (hazard ratio 1.89, 95%CI 1.32–2.70) (Fig. 1, online Supporting Information Tables S1 and S2).&lt;/p&gt;&lt;p&gt;In the unadjusted analysis, the adjusted median (IQR [range]) 1-year HRQoL was lower in patients with two or more long-term conditions compared with those with one long-term condition (0.783 (0.625–1.000 [-0.743–1.000]) vs. 1.000 (0.799–1.000 [-1.069–1.000]), p &lt; 0.001). After adjustment, however, this difference was not statistically significant: coefficient -0.02, 95%CI -0.04 to -0.003, p &lt; 0.095 (online Supporting Information Figure S2 and Table S3).&lt;/p&gt;&lt;p&gt;We found lower survival for patients with long-term conditions, most commonly HIV, hypertension and diabetes mellitus. This is important because complications from these primary chronic communicable and non-communicable diseas","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"81 2","pages":"297-299"},"PeriodicalIF":6.9,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/epdf/10.1111/anae.70083","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145516275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sugammadex hypersensitivity: a national retrospective cohort study from the French pharmacovigilance database 糖madex过敏:一项来自法国药物警戒数据库的全国性回顾性队列研究
IF 6.9 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-14 DOI: 10.1111/anae.70077
Nory Elhadjene, Marlène Damin-Pernik, Serge Molliex, Cédric Delzanno, Louise Triquet
{"title":"Sugammadex hypersensitivity: a national retrospective cohort study from the French pharmacovigilance database","authors":"Nory Elhadjene,&nbsp;Marlène Damin-Pernik,&nbsp;Serge Molliex,&nbsp;Cédric Delzanno,&nbsp;Louise Triquet","doi":"10.1111/anae.70077","DOIUrl":"10.1111/anae.70077","url":null,"abstract":"","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"81 3","pages":"434-435"},"PeriodicalIF":6.9,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/epdf/10.1111/anae.70077","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145515778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue Information – Editorial Board 发行信息-编辑委员会
IF 6.9 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-13 DOI: 10.1111/anae.16350
{"title":"Issue Information – Editorial Board","authors":"","doi":"10.1111/anae.16350","DOIUrl":"https://doi.org/10.1111/anae.16350","url":null,"abstract":"","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"80 12","pages":""},"PeriodicalIF":6.9,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/epdf/10.1111/anae.16350","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peri-operative hypersensitivity reactions to neuromuscular blocking drugs in New Zealand 2013-2019: a retrospective observational study. 2013-2019年新西兰神经肌肉阻断药物围手术期超敏反应回顾性观察研究
IF 10.7 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-10 DOI: 10.1111/anae.70058
Karen Pedersen,Johan van Schalkwyk,Kim Phillips,Henry Wang,Peter Cooke
INTRODUCTIONPeri-operative hypersensitivity reactions are rare and unpredictable events that can result in significant patient harm. Neuromuscular blocking drugs are one of the leading causes of peri-operative hypersensitivity reactions in many parts of the world.METHODSOur retrospective observational cohort study of in adults in New Zealand investigated the incidence and relative risk of a peri-operative hypersensitivity reaction to the various to neuromuscular blocking drugs. We also explored possible cross-sensitivity between the different neuromuscular blocking drugs using skin testing. The incidence of anaphylaxis to neuromuscular blocking drugs was calculated within a subset of our cohort, using confirmed cases of anaphylaxis to each neuromuscular blocking drug as the numerator and number of new patient exposures to the drug as the denominator.RESULTSWe determined the risk of a peri-operative hypersensitivity reaction with individual neuromuscular blocking drugs to be: suxamethonium 1:1500 (95%CI 1000-2500); rocuronium 1:3300 (95%CI 2100-5300); and atracurium 1:15,000 (95%CI 6800-40,000). Female patients were up to eight times more likely to experience a peri-operative hypersensitivity reaction than males. Our skin test results suggest that if a patient experiences a peri-operative hypersensitivity reaction to rocuronium, suxamethonium or vecuronium, then atracurium is the lowest risk alternative. If a patient has had a peri-operative hypersensitivity reaction to atracurium, then rocuronium and suxamethonium are low risk alternatives.DISCUSSIONWe found a significant difference between the rates of peri-operative hypersensitivity reactions with rocuronium and suxamethonium vs. atracurium. The increased risk of a peri-operative hypersensitivity reaction is a factor that should be weighed against the benefits of using suxamethonium or rocuronium. Females may be higher risk than males of reacting to neuromuscular blocking drugs.
围手术期超敏反应是罕见且不可预测的事件,可导致严重的患者伤害。神经肌肉阻断药物是世界上许多地区围手术期过敏反应的主要原因之一。方法一项回顾性观察队列研究调查了新西兰成年人对各种神经肌肉阻断药物的围手术期超敏反应的发生率和相对风险。我们还通过皮肤试验探讨了不同神经肌肉阻断药物之间可能的交叉敏感性。神经肌肉阻断药物的过敏反应发生率是在我们队列的一个子集中计算的,使用每种神经肌肉阻断药物的确诊过敏反应病例作为分子,新患者接触药物的数量作为分母。结果我们确定单个神经肌肉阻断药物围手术期超敏反应的风险为:苏沙霉素1:1500 (95%CI 1000-2500);罗库溴铵1:3300 (95%CI 2100-5300);阿曲库铵1:15 000 (95%CI 6800- 40000)。女性患者出现围手术期超敏反应的可能性是男性患者的8倍。我们的皮肤试验结果表明,如果患者对罗库溴铵、苏沙莫铵或维库溴铵出现围手术期过敏反应,那么阿曲库铵是风险最低的选择。如果患者对阿曲库铵有围手术期超敏反应,那么罗库溴铵和苏沙莫铵是低风险的替代品。讨论:我们发现罗库溴铵和苏沙莫铵与阿曲库铵围手术期超敏反应的发生率有显著差异。围手术期超敏反应风险的增加是与使用苏沙莫铵或罗库溴铵的益处相权衡的一个因素。女性可能比男性更容易对神经肌肉阻断药物产生反应。
{"title":"Peri-operative hypersensitivity reactions to neuromuscular blocking drugs in New Zealand 2013-2019: a retrospective observational study.","authors":"Karen Pedersen,Johan van Schalkwyk,Kim Phillips,Henry Wang,Peter Cooke","doi":"10.1111/anae.70058","DOIUrl":"https://doi.org/10.1111/anae.70058","url":null,"abstract":"INTRODUCTIONPeri-operative hypersensitivity reactions are rare and unpredictable events that can result in significant patient harm. Neuromuscular blocking drugs are one of the leading causes of peri-operative hypersensitivity reactions in many parts of the world.METHODSOur retrospective observational cohort study of in adults in New Zealand investigated the incidence and relative risk of a peri-operative hypersensitivity reaction to the various to neuromuscular blocking drugs. We also explored possible cross-sensitivity between the different neuromuscular blocking drugs using skin testing. The incidence of anaphylaxis to neuromuscular blocking drugs was calculated within a subset of our cohort, using confirmed cases of anaphylaxis to each neuromuscular blocking drug as the numerator and number of new patient exposures to the drug as the denominator.RESULTSWe determined the risk of a peri-operative hypersensitivity reaction with individual neuromuscular blocking drugs to be: suxamethonium 1:1500 (95%CI 1000-2500); rocuronium 1:3300 (95%CI 2100-5300); and atracurium 1:15,000 (95%CI 6800-40,000). Female patients were up to eight times more likely to experience a peri-operative hypersensitivity reaction than males. Our skin test results suggest that if a patient experiences a peri-operative hypersensitivity reaction to rocuronium, suxamethonium or vecuronium, then atracurium is the lowest risk alternative. If a patient has had a peri-operative hypersensitivity reaction to atracurium, then rocuronium and suxamethonium are low risk alternatives.DISCUSSIONWe found a significant difference between the rates of peri-operative hypersensitivity reactions with rocuronium and suxamethonium vs. atracurium. The increased risk of a peri-operative hypersensitivity reaction is a factor that should be weighed against the benefits of using suxamethonium or rocuronium. Females may be higher risk than males of reacting to neuromuscular blocking drugs.","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"29 1","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of the pre-operative measurement of fractional exhaled nitric oxide and respiratory mechanics to predict respiratory outcomes in children undergoing general anaesthesia 术前测量呼出一氧化氮分数和呼吸力学预测全麻患儿呼吸结局的可行性。
IF 6.9 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-10 DOI: 10.1111/anae.70056
Neil Hauser, David Sommerfield, Julie Nguyen, Aine Sommerfield, Daisy Evans, R. Nazim Khan, Chris O'Dea, Britta S von Ungern-Sternberg

Introduction

Peri-operative respiratory adverse events remain a major cause of morbidity and mortality in children undergoing general anaesthesia; those with asthma are at higher risk. The aim of this feasibility study was to determine whether pre-operative measurements of fractional exhaled nitric oxide and the forced oscillation technique are feasible in children, and to explore whether these measurements can predict peri-operative respiratory adverse events.

Methods

We assigned children into respiratory or control groups, according to the presence or absence of respiratory symptoms. We recorded pre-operative measurements of fractional exhaled nitric oxide as well as respiratory mechanics, as determined by the forced oscillation technique. We then recorded the incidence of peri-operative respiratory adverse events.

Results

We enrolled 120 children of which 116 were included. Fractional exhaled nitric oxide and respiratory mechanics (forced oscillation technique) were recorded in 106/116 (91%) and 71/116 (61%), respectively. Peri-operative respiratory adverse events occurred in 17/116 (15%) patients but there was no difference between groups (OR 2.11, 95%CI 0.74–6.55). Pre-operative fractional exhaled nitric oxide levels did not predict the occurrence of peri-operative respiratory adverse events. The measurement of respiratory mechanics using the forced oscillation technique did not predict peri-operative respiratory adverse events.

Discussion

We have shown the feasibility of study enrolment and pre-operative fractional exhaled nitric oxide measurement but had difficulty obtaining measurements of respiratory mechanics (forced oscillation technique). Neither test improved the prediction of peri-operative respiratory adverse events reliably in this group of patients. A thorough pre-operative clinical history combined with care by an experienced paediatric anaesthetist remains the most reliable means of reducing peri-operative respiratory adverse events.

围手术期呼吸不良事件仍然是全麻患儿发病和死亡的主要原因;哮喘患者的风险更高。本可行性研究的目的是确定术前测量分次呼出一氧化氮和强迫振荡技术在儿童中是否可行,并探讨这些测量是否可以预测围手术期呼吸不良事件。方法根据患儿有无呼吸道症状,将患儿分为呼吸组和对照组。我们记录了术前呼出一氧化氮的分数以及呼吸力学的测量,由强迫振荡技术确定。然后记录围手术期呼吸不良事件的发生率。结果共纳入120例儿童,其中116例纳入研究。分别在106/116(91%)和71/116(61%)记录呼出一氧化氮分数和呼吸力学(强迫振荡技术)。17/116(15%)患者发生围手术期呼吸不良事件,但组间无差异(OR 2.11, 95%CI 0.74-6.55)。术前呼出一氧化氮分数水平不能预测围手术期呼吸不良事件的发生。使用强迫振荡技术测量呼吸力学不能预测围手术期呼吸不良事件。我们已经证明了研究入组和术前呼气一氧化氮分数测量的可行性,但难以获得呼吸力学测量(强迫振荡技术)。这两项试验都不能可靠地改善本组患者围手术期呼吸不良事件的预测。全面的术前临床病史结合经验丰富的儿科麻醉师的护理仍然是减少围手术期呼吸不良事件的最可靠手段。
{"title":"Feasibility of the pre-operative measurement of fractional exhaled nitric oxide and respiratory mechanics to predict respiratory outcomes in children undergoing general anaesthesia","authors":"Neil Hauser,&nbsp;David Sommerfield,&nbsp;Julie Nguyen,&nbsp;Aine Sommerfield,&nbsp;Daisy Evans,&nbsp;R. Nazim Khan,&nbsp;Chris O'Dea,&nbsp;Britta S von Ungern-Sternberg","doi":"10.1111/anae.70056","DOIUrl":"10.1111/anae.70056","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Peri-operative respiratory adverse events remain a major cause of morbidity and mortality in children undergoing general anaesthesia; those with asthma are at higher risk. The aim of this feasibility study was to determine whether pre-operative measurements of fractional exhaled nitric oxide and the forced oscillation technique are feasible in children, and to explore whether these measurements can predict peri-operative respiratory adverse events.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We assigned children into respiratory or control groups, according to the presence or absence of respiratory symptoms. We recorded pre-operative measurements of fractional exhaled nitric oxide as well as respiratory mechanics, as determined by the forced oscillation technique. We then recorded the incidence of peri-operative respiratory adverse events.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We enrolled 120 children of which 116 were included. Fractional exhaled nitric oxide and respiratory mechanics (forced oscillation technique) were recorded in 106/116 (91%) and 71/116 (61%), respectively. Peri-operative respiratory adverse events occurred in 17/116 (15%) patients but there was no difference between groups (OR 2.11, 95%CI 0.74–6.55). Pre-operative fractional exhaled nitric oxide levels did not predict the occurrence of peri-operative respiratory adverse events. The measurement of respiratory mechanics using the forced oscillation technique did not predict peri-operative respiratory adverse events.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>We have shown the feasibility of study enrolment and pre-operative fractional exhaled nitric oxide measurement but had difficulty obtaining measurements of respiratory mechanics (forced oscillation technique). Neither test improved the prediction of peri-operative respiratory adverse events reliably in this group of patients. A thorough pre-operative clinical history combined with care by an experienced paediatric anaesthetist remains the most reliable means of reducing peri-operative respiratory adverse events.</p>\u0000 </section>\u0000 </div>","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"81 3","pages":"395-401"},"PeriodicalIF":6.9,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of body mass index on postoperative recovery to independent living: a retrospective cohort study. 体重指数对术后恢复独立生活的影响:一项回顾性队列研究
IF 10.7 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-10 DOI: 10.1111/anae.70059
Annika Bald,Rafi Khandaker,Felix Borngaesser,Jenny J Choi,Christian Mpody,Karuna Wongtangman,Tina Ramishvili,Philipp Fassbender,Olubukola Nafiu,Maíra I Rudolph,Matthias Eikermann,Daniel Thomas-Rüddel
INTRODUCTIONLiving with obesity is a risk factor for diabetes, cardiovascular disease and cancer. The 'obesity paradox' suggests patients who are overweight or living with mild obesity experience better outcomes after surgery and critical illness compared with patients living with normal weight. However, little is known about the generalisability and possible mechanisms of the obesity paradox. This study investigated the relationship between BMI and loss of independent living after surgery.METHODSWe analysed adult patients who lived independently before non-cardiac, non-bariatric, non-ambulatory surgery. We used a multivariable restricted cubic spline model, with a BMI of 22.0 kg.m-2 set as our reference point. The primary outcome was loss of independent living (adverse discharge), defined as in-hospital mortality or discharge to a skilled nursing facility.RESULTSAmong 73,813 patients, 9495 (12.9%) were unable to live independently after surgery. Adjusted analyses showed a U-shaped relationship between BMI and adverse discharge, with calculated risk ratios and confidence intervals for each distinct BMI in the cohort compared with our reference weight of 22.0 kg.m-2. Patients who were underweight had significantly elevated risks (adjusted risk ratio (aRR) 1.46 (95%CI 1.34-1.59) for patients with BMI 15.0 kg.m-2). Similarly, patients living with severe obesity had a higher risk of adverse discharge destination (aRR 1.07 (95%CI 1.01-1.13) and 1.36 (95%CI 1.24-1.48) for patients with BMIs of 40.0 kg.m-2 and 50.0 kg.m-2, respectively). In contrast, patients who were overweight or living with obesity class 1 had reduced risks of adverse discharge (aRR 0.90 (95%CI 0.88-0.92) and 0.89 (95%CI 0.84-0.94) for BMIs of 25.0 kg.m-2 and 30.0 kg.m-2, respectively).DISCUSSIONThis study shows a U-shaped relationship between BMI and the risk of postoperative loss of independent living. Patients with mild obesity experienced a lower risk of losing the ability to live independently after surgery.
肥胖是患糖尿病、心血管疾病和癌症的危险因素。“肥胖悖论”表明,与体重正常的患者相比,超重或轻度肥胖的患者在手术和危重疾病后的预后更好。然而,人们对肥胖悖论的普遍性和可能的机制知之甚少。本研究探讨了BMI与术后独立生活能力丧失的关系。方法我们分析了非心脏、非减肥、非门诊手术前独立生活的成年患者。我们采用多变量受限三次样条模型,BMI为22.0 kg。M-2集合作为参考点。主要结局是丧失独立生活(不良出院),定义为住院死亡率或出院到专业护理机构。结果73813例患者中,9495例(12.9%)术后不能独立生活。调整后的分析显示BMI和不良排出之间呈u型关系,与我们的参考体重22.0 kg.m-2相比,队列中每个不同BMI的计算风险比和置信区间。体重过轻的患者风险显著升高(BMI为15.0 kg.m-2的患者调整风险比(aRR) 1.46 (95%CI 1.34-1.59))。同样,重度肥胖患者出现不良出院目的地的风险更高,bmi为40.0 kg的患者aRR为1.07 (95%CI 1.01-1.13), aRR为1.36 (95%CI 1.24-1.48)。M-2和50.0公斤。分别为m - 2)。相比之下,超重或1级肥胖患者的不良出院风险降低(aRR 0.90 (95%CI 0.88-0.92)和0.89 (95%CI 0.84-0.94), bmi为25.0 kg。M-2和30.0公斤。分别为m - 2)。本研究显示BMI与术后独立生活丧失风险呈u型关系。轻度肥胖患者术后失去独立生活能力的风险较低。
{"title":"Effect of body mass index on postoperative recovery to independent living: a retrospective cohort study.","authors":"Annika Bald,Rafi Khandaker,Felix Borngaesser,Jenny J Choi,Christian Mpody,Karuna Wongtangman,Tina Ramishvili,Philipp Fassbender,Olubukola Nafiu,Maíra I Rudolph,Matthias Eikermann,Daniel Thomas-Rüddel","doi":"10.1111/anae.70059","DOIUrl":"https://doi.org/10.1111/anae.70059","url":null,"abstract":"INTRODUCTIONLiving with obesity is a risk factor for diabetes, cardiovascular disease and cancer. The 'obesity paradox' suggests patients who are overweight or living with mild obesity experience better outcomes after surgery and critical illness compared with patients living with normal weight. However, little is known about the generalisability and possible mechanisms of the obesity paradox. This study investigated the relationship between BMI and loss of independent living after surgery.METHODSWe analysed adult patients who lived independently before non-cardiac, non-bariatric, non-ambulatory surgery. We used a multivariable restricted cubic spline model, with a BMI of 22.0 kg.m-2 set as our reference point. The primary outcome was loss of independent living (adverse discharge), defined as in-hospital mortality or discharge to a skilled nursing facility.RESULTSAmong 73,813 patients, 9495 (12.9%) were unable to live independently after surgery. Adjusted analyses showed a U-shaped relationship between BMI and adverse discharge, with calculated risk ratios and confidence intervals for each distinct BMI in the cohort compared with our reference weight of 22.0 kg.m-2. Patients who were underweight had significantly elevated risks (adjusted risk ratio (aRR) 1.46 (95%CI 1.34-1.59) for patients with BMI 15.0 kg.m-2). Similarly, patients living with severe obesity had a higher risk of adverse discharge destination (aRR 1.07 (95%CI 1.01-1.13) and 1.36 (95%CI 1.24-1.48) for patients with BMIs of 40.0 kg.m-2 and 50.0 kg.m-2, respectively). In contrast, patients who were overweight or living with obesity class 1 had reduced risks of adverse discharge (aRR 0.90 (95%CI 0.88-0.92) and 0.89 (95%CI 0.84-0.94) for BMIs of 25.0 kg.m-2 and 30.0 kg.m-2, respectively).DISCUSSIONThis study shows a U-shaped relationship between BMI and the risk of postoperative loss of independent living. Patients with mild obesity experienced a lower risk of losing the ability to live independently after surgery.","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"80 1","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structural and organisational impacts of peri-operative enhanced care services in the UK: a Retrospective Evaluation of Postoperative Alternatives to Critical Care (REPACC). 英国围手术期强化护理服务的结构和组织影响:对术后重症护理替代方案(REPACC)的回顾性评估。
IF 10.7 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-10 DOI: 10.1111/anae.70057
Christopher Oddy,Dominic Lowcock,Thomas W Davies,Sarah Towey,Mark Burnett,Amanda Davis,Gareth Davey,Adam Green,Olivia Bools,Michael Coulton,Henry Lewith,Paolo Perella,Danny J N Wong, ,
INTRODUCTIONThe enhanced care model of peri-operative care has evolved to meet increasing surgical demand, aiming to relieve pressure on critical care and prevent unnecessary cancellation of surgery. Despite widespread adoption of these facilities in the UK, no resources currently describe the national landscape of enhanced care or the organisational impacts of their introduction.METHODSWe conducted a UK-wide, retrospective, observational study. At each site, the local structure of enhanced (level 1) and critical care (levels 2-3) services was recorded alongside time-series data describing patient flow and individual details for all referrals to levels 1-3. Multilevel regression was used to explore the relationships between referral to an enhanced care facility and various organisational outcomes. A cluster analysis was performed to group enhanced care units with similar characteristics.RESULTSData were collected between September and November 2023. Of 110 participating centres, 70 (63.6%) had a surgical level 1 unit. In total, 5990 patient referrals to levels 1-3 were followed up, of which 3146 (52.5%) were referred to level 1 and 2844 (47.5%) to levels 2-3. Enhanced care patients were younger, with fewer comorbidities, and were undergoing less complex surgery than those referred to critical care. Referral to level 1 rather than levels 2-3 was associated with a reduced likelihood of cancellation (OR 0.50, 95%CI 0.40-0.64, p < 0.001); cancellation due to a lack of bed (OR 0.27, 95%CI 0.19-0.40, p < 0.001); and a shorter duration of hospital stay (incidence risk ratio 0.58, 95%CI 0.55-0.61, p < 0.001).DISCUSSIONEnhanced care services provide a suitable alternative to critical care for high-risk surgical patients in the UK whilst building surgical capacity and system resilience. These facilities are associated with improved organisational outcomes, associations which may reflect both operational efficiency and the lower clinical acuity of the population they serve.
围手术期强化护理模式的发展是为了满足日益增长的手术需求,旨在减轻重症监护的压力,防止不必要的手术取消。尽管这些设施在英国被广泛采用,但目前没有资源描述加强护理的国家景观或它们的引入对组织的影响。方法我们进行了一项全英国范围的回顾性观察性研究。在每个站点,记录了当地强化(1级)和重症监护(2-3级)服务的结构,以及描述患者流程和所有转介至1-3级的个人详细信息的时间序列数据。使用多水平回归来探索转诊到强化护理机构和各种组织结果之间的关系。对具有相似特征的强化护理单位进行聚类分析。结果数据采集时间为2023年9 - 11月。在110个参与的中心中,70个(63.6%)有一级外科科室。总共随访了5990例转诊至1-3级的患者,其中3146例(52.5%)转诊至1级,2844例(47.5%)转诊至2-3级。强化护理的患者更年轻,合并症更少,接受的手术比重症监护的患者更简单。转介到1级而不是2-3级与降低取消的可能性相关(OR 0.50, 95%CI 0.40-0.64, p < 0.001);因床位不足而取消(OR 0.27, 95%CI 0.19-0.40, p < 0.001);住院时间较短(发病率风险比0.58,95%CI 0.55 ~ 0.61, p < 0.001)。讨论增强的护理服务提供了一个合适的替代重症监护高危手术患者在英国,同时建立手术能力和系统弹性。这些设施与改善的组织成果有关,这些联系可能反映了运营效率和他们所服务的人群的临床敏锐度较低。
{"title":"Structural and organisational impacts of peri-operative enhanced care services in the UK: a Retrospective Evaluation of Postoperative Alternatives to Critical Care (REPACC).","authors":"Christopher Oddy,Dominic Lowcock,Thomas W Davies,Sarah Towey,Mark Burnett,Amanda Davis,Gareth Davey,Adam Green,Olivia Bools,Michael Coulton,Henry Lewith,Paolo Perella,Danny J N Wong, , ","doi":"10.1111/anae.70057","DOIUrl":"https://doi.org/10.1111/anae.70057","url":null,"abstract":"INTRODUCTIONThe enhanced care model of peri-operative care has evolved to meet increasing surgical demand, aiming to relieve pressure on critical care and prevent unnecessary cancellation of surgery. Despite widespread adoption of these facilities in the UK, no resources currently describe the national landscape of enhanced care or the organisational impacts of their introduction.METHODSWe conducted a UK-wide, retrospective, observational study. At each site, the local structure of enhanced (level 1) and critical care (levels 2-3) services was recorded alongside time-series data describing patient flow and individual details for all referrals to levels 1-3. Multilevel regression was used to explore the relationships between referral to an enhanced care facility and various organisational outcomes. A cluster analysis was performed to group enhanced care units with similar characteristics.RESULTSData were collected between September and November 2023. Of 110 participating centres, 70 (63.6%) had a surgical level 1 unit. In total, 5990 patient referrals to levels 1-3 were followed up, of which 3146 (52.5%) were referred to level 1 and 2844 (47.5%) to levels 2-3. Enhanced care patients were younger, with fewer comorbidities, and were undergoing less complex surgery than those referred to critical care. Referral to level 1 rather than levels 2-3 was associated with a reduced likelihood of cancellation (OR 0.50, 95%CI 0.40-0.64, p < 0.001); cancellation due to a lack of bed (OR 0.27, 95%CI 0.19-0.40, p < 0.001); and a shorter duration of hospital stay (incidence risk ratio 0.58, 95%CI 0.55-0.61, p < 0.001).DISCUSSIONEnhanced care services provide a suitable alternative to critical care for high-risk surgical patients in the UK whilst building surgical capacity and system resilience. These facilities are associated with improved organisational outcomes, associations which may reflect both operational efficiency and the lower clinical acuity of the population they serve.","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"162 1","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of noradrenaline, vasopressin, phenylephrine or metaraminol on kidney and brain microcirculation in ovine cardiopulmonary bypass: a randomised trial 去甲肾上腺素、加压素、苯肾上腺素或去甲氨醇对绵羊体外循环肾和脑微循环的影响:一项随机试验。
IF 6.9 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-10 DOI: 10.1111/anae.70049
Alemayehu H. Jufar, Clive N. May, Taku Furukawa, Roger G. Evans, Andrew D. Cochrane, Bruno Marino, Jaishankar Raman, Peter R. McCall, Abraham Hulst, Sally G. Hood, Anton Trask-Marino, Rinaldo Bellomo, Lachlan F. Miles, Yugeesh R. Lankadeva

Introduction

Intra-operative hypotension is common during cardiopulmonary bypass and may contribute to tissue hypoxia. Tissue hypoxia has been linked to the development of postoperative kidney and brain injury. Vasopressors are used to treat hypotension during and after cardiopulmonary bypass. However, the effects of these drugs on renal and cerebral tissue oxygenation and perfusion are unknown. We tested the effects of four vasopressors on renal and cerebral tissue perfusion and oxygenation in a clinically-relevant ovine model of cardiopulmonary bypass.

Methods

We studied 16 sheep before and after induction of anaesthesia and during 2.5 h of cardiopulmonary bypass. After commencing cardiopulmonary bypass at a target non-pulsatile flow of 2.4 l.min-1.m-2, we observed a baseline period with a target mean arterial pressure of 50–60 mmHg, after which we targeted a mean arterial pressure of 75–85 mmHg using a continuous infusion of metaraminol (n = 8); noradrenaline (n = 8); phenylephrine (n = 8); or vasopressin (n = 7). Sheep were allocated randomly to receive two of the four vasopressors.

Results

Compared with the pre-induction state, cardiopulmonary bypass significantly decreased renal medullary tissue perfusion (median (IQR [range]) decrease 55 (4–82 [1–99])%; p = 0.01) and medullary oxygen tension (mean (SD) difference 3.1 (2.5) kPa; p < 0.001). Cardiopulmonary bypass did not significantly alter cerebral tissue perfusion or oxygenation compared with the pre-induction state. Infusing noradrenaline significantly decreased medullary oxygen tension (mean (SD) difference 2.7 (1.6) kPa; p = 0.003). This decrease in medullary oxygen tension was significant compared with vasopressin (mean difference -3.4 kPa, 95%CI -5.7 to -1.0; p = 0.008). No vasopressor infusion significantly altered renal medullary perfusion, cerebral tissue perfusion or oxygenation.

Discussion

Intra-operative noradrenaline during ovine cardiopulmonary bypass worsens renal medullary tissue oxygenation relative to vasopressin. These findings suggest that the choice of vasopressors may affect renal oxygenation.

术中低血压在体外循环手术中很常见,并可能导致组织缺氧。组织缺氧与术后肾和脑损伤的发展有关。血管加压药用于治疗体外循环期间和之后的低血压。然而,这些药物对肾脏和脑组织氧合和灌注的影响尚不清楚。我们在临床相关的绵羊体外循环模型中测试了四种血管加压药对肾脏和脑组织灌注和氧合的影响。方法对16只绵羊麻醉前后及体外循环2.5 h进行研究。在目标非搏动流量2.4 l / min-1下开始体外循环后。m-2,我们观察到基线期的目标平均动脉压为50-60 mmHg,之后我们通过持续输注甲氨醇将目标平均动脉压定为75-85 mmHg (n = 8);去甲肾上腺素8例;苯肾上腺素(n = 8);抗利尿激素(n = 7)。羊被随机分配接受四种血管加压药中的两种。结果与诱导前相比,体外循环显著降低肾髓质组织灌注(中位数(IQR [range])降低55 (4 ~ 82 [1 ~ 99])%;p = 0.01)和髓质氧张力(平均(SD)差3.1 (2.5)kPa;p < 0.001)。与诱导前相比,体外循环对脑组织灌注和氧合无明显影响。输注去甲肾上腺素显著降低髓质氧张力(SD差2.7 (1.6)kPa);p = 0.003)。与抗利尿激素相比,髓质氧张力显著降低(平均差值为-3.4 kPa, 95%CI为-5.7至-1.0;p = 0.008)。无血管加压素输注显著改变肾髓质灌注、脑组织灌注或氧合。讨论:相对于利尿激素,绵羊体外循环术中去甲肾上腺素使肾髓组织氧合恶化。这些发现提示血管加压剂的选择可能影响肾氧合。
{"title":"Effects of noradrenaline, vasopressin, phenylephrine or metaraminol on kidney and brain microcirculation in ovine cardiopulmonary bypass: a randomised trial","authors":"Alemayehu H. Jufar,&nbsp;Clive N. May,&nbsp;Taku Furukawa,&nbsp;Roger G. Evans,&nbsp;Andrew D. Cochrane,&nbsp;Bruno Marino,&nbsp;Jaishankar Raman,&nbsp;Peter R. McCall,&nbsp;Abraham Hulst,&nbsp;Sally G. Hood,&nbsp;Anton Trask-Marino,&nbsp;Rinaldo Bellomo,&nbsp;Lachlan F. Miles,&nbsp;Yugeesh R. Lankadeva","doi":"10.1111/anae.70049","DOIUrl":"10.1111/anae.70049","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Intra-operative hypotension is common during cardiopulmonary bypass and may contribute to tissue hypoxia. Tissue hypoxia has been linked to the development of postoperative kidney and brain injury. Vasopressors are used to treat hypotension during and after cardiopulmonary bypass. However, the effects of these drugs on renal and cerebral tissue oxygenation and perfusion are unknown. We tested the effects of four vasopressors on renal and cerebral tissue perfusion and oxygenation in a clinically-relevant ovine model of cardiopulmonary bypass.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We studied 16 sheep before and after induction of anaesthesia and during 2.5 h of cardiopulmonary bypass. After commencing cardiopulmonary bypass at a target non-pulsatile flow of 2.4 l.min<sup>-1</sup>.m<sup>-2</sup>, we observed a baseline period with a target mean arterial pressure of 50–60 mmHg, after which we targeted a mean arterial pressure of 75–85 mmHg using a continuous infusion of metaraminol (n = 8); noradrenaline (n = 8); phenylephrine (n = 8); or vasopressin (n = 7). Sheep were allocated randomly to receive two of the four vasopressors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Compared with the pre-induction state, cardiopulmonary bypass significantly decreased renal medullary tissue perfusion (median (IQR [range]) decrease 55 (4–82 [1–99])%; p = 0.01) and medullary oxygen tension (mean (SD) difference 3.1 (2.5) kPa; p &lt; 0.001). Cardiopulmonary bypass did not significantly alter cerebral tissue perfusion or oxygenation compared with the pre-induction state. Infusing noradrenaline significantly decreased medullary oxygen tension (mean (SD) difference 2.7 (1.6) kPa; p = 0.003). This decrease in medullary oxygen tension was significant compared with vasopressin (mean difference -3.4 kPa, 95%CI -5.7 to -1.0; p = 0.008). No vasopressor infusion significantly altered renal medullary perfusion, cerebral tissue perfusion or oxygenation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>Intra-operative noradrenaline during ovine cardiopulmonary bypass worsens renal medullary tissue oxygenation relative to vasopressin. These findings suggest that the choice of vasopressors may affect renal oxygenation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"81 3","pages":"383-394"},"PeriodicalIF":6.9,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpreting injectate spread in lumbar erector spinae plane block 腰椎竖肌棘平面阻滞中注射扩散的解释
IF 10.7 1区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-11-08 DOI: 10.1111/anae.70070
Güneş Çelebioğlu
{"title":"Interpreting injectate spread in lumbar erector spinae plane block","authors":"Güneş Çelebioğlu","doi":"10.1111/anae.70070","DOIUrl":"https://doi.org/10.1111/anae.70070","url":null,"abstract":"","PeriodicalId":7742,"journal":{"name":"Anaesthesia","volume":"2021 1","pages":""},"PeriodicalIF":10.7,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145461324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anaesthesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1